FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jacob Rowe

Research Profile

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Irit Avivi; Eldad J Dann; Tal Faibish; Ronit Leiba; Jacob M Rowe; Ariel Zilberlicht; Rachel Bar-Shalom
Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
Stephen J Forman; Jacob M Rowe
The myth of the second remission of acute leukemia in the adult.
Yishai Ofran; Jacob M Rowe
Genetic profiling in acute myeloid leukaemia--where are we and what is its role in patient management.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jacob Rowe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Irit Avivi; Eldad J Dann; Tal Faibish; Ronit Leiba; Jacob M Rowe; Ariel Zilberlicht; Rachel Bar-Shalom
Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
American journal of hematology 2013;88(5):400-5.
2013: Stephen J Forman; Jacob M Rowe
The myth of the second remission of acute leukemia in the adult.
Blood 2013;121(7):1077-82.
2013: Yishai Ofran; Jacob M Rowe
Genetic profiling in acute myeloid leukaemia--where are we and what is its role in patient management.
British journal of haematology 2013;160(3):303-20.
2013: Irit Avivi; Jacob M Rowe; Dina Stroopinsky; Tamar Katz
A subset of CD8+ T cells acquiring selective suppressive properties may play a role in GvHD management.
Transplant immunology 2013;28(1):57-61.
2012: Jacob M Rowe
The impact of mutational profiling on AML prognosis.
Best practice & research. Clinical haematology 2012;25(4):403-8.
2012: Tsila Zuckerman; Martin S Tallman; Chezi Ganzel; Jacob M Rowe
How I treat hematologic emergencies in adults with acute leukemia.
Blood 2012;120(10):1993-2002.
2012: Tsila Zuckerman; Edmond Sabo; Dvora Sahar; Irit Avivi; Eldad J Dann; Tal Faibish; Riva Fineman; Israel Gavish; Nuhad Haddad; Eti Hertz; Tamar Katz; Yishay Ofran; Yair Reisner; Jacob M Rowe
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia: risk stratified approach with a long-term follow-up.
American journal of hematology 2012;87(9):875-9.
2012: Dina Stroopinsky; Tamar Katz; Doron Melamed; Jacob M Rowe; Irit Avivi
Rituximab-induced direct inhibition of T-cell activation.
Cancer immunology, immunotherapy : CII 2012;61(8):1233-41.
2012: Liran Shlush; Roni Shouval; Karl Skorecki; Adam Spiro; Maty Tzukerman; Tsila Zuckerman; Rivka Adar; Dani Bercovich; Clara D Bloomfield; Noa Chapal-Ilani; Shai Izraeli; Guido Marcucci; Yosef Maruvka; Neta Pery; Jacob M Rowe; Ehud Shapiro
Cell lineage analysis of acute leukemia relapse uncovers the role of replication-rate heterogeneity and microsatellite instability.
Blood 2012;120(3):603-12.
2012: Norberto Krivoy; Jacob M Rowe; Tsila Zuckerman; Hela Elkin; Lia Froymovich; Edna Efrati
Pharmacokinetic and pharmacogenetic analysis of oral busulfan in stem cell transplantation: prediction of poor drug metabolism to prevent drug toxicity.
Current drug safety 2012;7(3):211-7.
2012: Yishai Ofran; Jacob M Rowe
Treatment for relapsed acute myeloid leukemia: what is new?
Current opinion in hematology 2012;19(2):89-94.
2012: Yishai Ofran; Ora Paltiel; Dan Pelleg; Jacob M Rowe; Elad Yom-Tov
Patterns of information-seeking for cancer on the internet: an analysis of real world data.
PloS one 2012;7(9):e45921.
2012: Emilia Hardak; Ilana Oren; Jacob M Rowe; Mordechai Yigla; Eldad J Dann; Tal Faibish; Irit Avivi
The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/sulfamethoxazole: a single-center experience.
Acta haematologica 2012;127(2):110-4.
2011: Irit Avivi; Riva Fineman; Nuhad Haddad; Tamar Katz; Ilana Oren; Jacob M Rowe; Tsila Zuckerman
Fatal Kaposi sarcoma after allogeneic stem cell transplant.
Leukemia & lymphoma 2011;52(12):2402-4.
2011: Tsila Zuckerman; Jacob M Rowe; Hannah Sprecher; N Benyamini; R Fineman; Renato Finkelstein; Ilana Oren
SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state.
Bone marrow transplantation 2011;46(9):1226-30.
2011: Yishai Ofran; Jacob M Rowe
Induction and postremission strategies in acute myeloid leukemia: what is new?
Current opinion in hematology 2011;18(2):83-8.
2011: Jacob M Rowe
Interpreting data on transplant selection and outcome in adult acute lymphoblastic leukemia (ALL).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(1 Suppl):S76-83.
2010: Jacob M Rowe
The evolving paradigm of prognostic factors in AML: Introduction to the Acute Leukemia Forum 2010.
Best practice & research. Clinical haematology 2010;23(4):453-6.
2010: Larry D Cripe; Hajime Uno; Elisabeth Paietta; Mark R Litzow; Rhett P Ketterling; John M Bennett; Jacob M Rowe; Hillard M Lazarus; Selina Luger; Martin S Tallman
Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999.
Blood 2010;116(20):4077-85.
2010: Peter H Wiernik; Janice P Dutcher; Xiapan Yao; Usha Venkatraj; Carla I Falkson; Jacob M Rowe; Peter A Cassileth
Phase II study of interleukin-4 in indolent B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E5Y92).
Journal of immunotherapy (Hagerstown, Md. : 1997) 2010;33(9):1006-9.
2010: Jacob M Rowe; Haesook T Kim; Peter A Cassileth; Hillard M Lazarus; Mark R Litzow; Peter H Wiernik; Martin S Tallman
Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology Group.
Cancer 2010;116(21):5012-21.
2010: Jacob M Rowe; Martin S Tallman
How I treat acute myeloid leukemia.
Blood 2010;116(17):3147-56.
2010: Jacob Pe'er; Jacob M Rowe; Shahar Frenkel; Eldad J Dann
Testicular lymphoma, intraocular (vitreoretinal) lymphoma, and brain lymphoma: involvement of three immunoprivileged sites in one patient.
American journal of hematology 2010;85(8):631-3.
2010: Jacob M Rowe
Prognostic factors in adult acute lymphoblastic leukaemia.
British journal of haematology 2010;150(4):389-405.
2010: Eldad J Dann; Rachel Bar-Shalom; Ada Tamir; Ron Epelbaum; Irit Avivi; Menachem Ben-Shachar; Diana Gaitini; Jacob M Rowe
A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphoma.
Haematologica 2010;95(7):1198-206.
2010: Ronit Elhasid; Jacob M Rowe
Hematopoetic stem cell transplantation in neutrophil disorders: severe congenital neutropenia, leukocyte adhesion deficiency and chronic granulomatous disease.
Clinical reviews in allergy & immunology 2010;38(1):61-7.
2009: Jacob M Rowe
Is there a role for intensifying induction therapy in acute myeloid leukaemia (AML)?
Best practice & research. Clinical haematology 2009;22(4):509-15.
2009: Jacob M Rowe
Advances and controversies in the biology and therapy of acute leukaemia and myelodysplasia.
Best practice & research. Clinical haematology 2009;22(4):475-8.
2009: Tsila Zuckerman; Jacob M Rowe
Hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia.
Current opinion in hematology 2009;16(6):453-9.
2009: Dina Stroopinsky; Irit Avivi; Jacob M Rowe; David Avigan; Tamar Katz
Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacity.
European journal of immunology 2009;39(10):2703-15.
2009: Peter L Greenberg; Zhuoxin Sun; Kenneth B Miller; John M Bennett; Martin S Tallman; Gordon Dewald; Elisabeth Paietta; Richard van der Jagt; Jessie G. Houston; Mary L Thomas; David Cella; Jacob M Rowe
Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996).
Blood 2009;114(12):2393-400.
2009: Marc R Mansour; Maria L Sulis; Veronique Duke; Letizia Foroni; Sarah Jenkinson; Kenneth Koo; Christopher G Allen; Rosemary E Gale; Georgina Buck; Sue Richards; Elisabeth Paietta; Jacob M Rowe; Martin S Tallman; Anthony H Goldstone; Adolfo Ferrando; David C Linch
Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(26):4352-6.
2009: Adele K Fielding; Jacob M Rowe; Susan M Richards; Georgina Buck; Anthony V Moorman; I Jill Durrant; David I Marks; Andrew K McMillan; Mark R Litzow; Hillard M Lazarus; Letizia Foroni; Gordon Dewald; Ian M Franklin; Selina M Luger; Elisabeth Paietta; Peter H Wiernik; Martin S Tallman; Anthony H Goldstone
Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993.
Blood 2009;113(19):4489-96.
2009: Jacob M Rowe
Closer to the truth in AML.
Blood 2009;113(18):4129-30.
2009: Ronit Elhasid; Yael A Leshem; Myriam Weyl Ben Arush; Jacob M Rowe; Naim Shehadeh
Insulin-related metabolism following hematopoietic stem cell transplantation in childhood.
Pediatric diabetes 2009;10(2):149-54.
2009: Jacob M Rowe
Optimal management of adults with ALL.
British journal of haematology 2009;144(4):468-83.
2009: Jacob M Rowe
Optimal induction and post-remission therapy for AML in first remission.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2009;():396-405.
2008: Jacob M Rowe
Clinical progress in acute myeloid leukemia. Preface.
Best practice & research. Clinical haematology 2008;21(4):597-9.
2008: Jacob M Rowe
Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
Best practice & research. Clinical haematology 2008;21(3):485-502.
2008: Anna Solomonov; Tsila Zuckerman; Ludmila Goralnik; Yehudit Ben-Arieh; Jacob M Rowe; Mordechai Yigla
Non-Hodgkin's lymphoma presenting as an endobronchial tumor: report of eight cases and literature review.
American journal of hematology 2008;83(5):416-9.
2008: Jacob M Rowe
Consolidation therapy: what should be the standard of care?
Best practice & research. Clinical haematology 2008;21(1):53-60.
2008: Anthony H Goldstone; Susan M Richards; Hillard M Lazarus; Martin S Tallman; Georgina Buck; Adele K Fielding; Alan K Burnett; rajesh Chopra; Peter H Wiernik; Letizia Foroni; Elisabeth Paietta; Mark R Litzow; David I Marks; Jill Durrant; Andrew McMillan; Ian M Franklin; Selina M Luger; Niculae Ciobanu; Jacob M Rowe
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993).
Blood 2008;111(4):1827-33.
2008: Zeev Blumenfeld; Irit Avivi; Ari Eckman; Ron Epelbaum; Jacob M Rowe; Eldad J Dann
Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma.
Fertility and sterility 2008;89(1):166-73.
2007: Yishay Ofran; Irit Avivi; Anna Oliven; Ilana Oren; Tsila Zuckerman; L Bonstein; Jacob M Rowe; Eldad J Dann
Granulocyte transfusions for neutropenic patients with life-threatening infections: a single centre experience in 47 patients, who received 348 granulocyte transfusions.
Vox sanguinis 2007;93(4):363-9.
2007: Jacob M Rowe; Anthony H Goldstone
How I treat acute lymphocytic leukemia in adults.
Blood 2007;110(7):2268-75.
2007: Ronit Lavi; Jacob M Rowe; Irit Avivi
Traumatic vs. atraumatic 22 G needle for therapeutic and diagnostic lumbar puncture in the hematologic patient: a prospective clinical trial.
Haematologica 2007;92(7):1007-8.
2007: Martin S Tallman; Gordon W Dewald; Sharavi Gandham; Brent R Logan; Armand Keating; Hillard M Lazarus; Mark R Litzow; Jayesh Mehta; Tanya Pedersen; Waleska S Pérez; Jacob M Rowe; Meir Wetzler; Daniel J Weisdorf
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission.
Blood 2007;110(1):409-17.
2007: Anthony V Moorman; Christine J Harrison; Georgina A N Buck; Susan M Richards; Lorna M Secker-Walker; Mary Martineau; Gail H Vance; Athena M Cherry; Rodney R Higgins; Adele K Fielding; Letizia Foroni; Elisabeth Paietta; Martin S Tallman; Mark R Litzow; Peter H Wiernik; Jacob M Rowe; Anthony H Goldstone; Gordon W Dewald
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.
Blood 2007;109(8):3189-97.
2007: Dejan Juric; Norman J Lacayo; Meghan C Ramsey; Janis Racevskis; Peter H Wiernik; Jacob M Rowe; Anthony H Goldstone; Peter J O'Dwyer; Elisabeth Paietta; Branimir I Sikic
Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(11):1341-9.
2007: Yishay Ofran; Irit Avivi; Benjamin Gesundheit; Reuven Or; Jacob M Rowe; Tsila Zuckerman
Differentiation syndrome with lethal lung injury after arsenic trioxide treatment for myelodysplastic syndrome.
American journal of hematology 2007;82(4):332-3.
2007: Ronit Elhasid; Myriam Ben Arush; Irena Zaidman; Ronit Leiba; Ayelet Ben Barak; Sergey Postovsky; Nuhad Haddad; Tamar Katz; Shimon Pollack; Ivanka Sami; Osnat Gidoni; Dina Rubin; Hanna Mandel; Dina Attias; Yair Reisner; Amos Etzioni; Jacob M Rowe
Safe and efficacious allogeneic bone marrow transplantation for nonmalignant disorders using partial T cell depletion and no posttransplantation graft-versus-host-disease prophylaxis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(3):329-38.
2007: Tsila Zuckerman; Jacob M Rowe
Alternative donor transplantation in acute myeloid leukemia: which source and when?
Current opinion in hematology 2007;14(2):152-61.
2007: Shaul Avraham; Luiza Akria; Eugene Vlodavsky; Jacob M Rowe
Granulocytic sarcoma with pulmonary involvement.
American journal of hematology 2007;82(3):222-3.
2007: Adele K Fielding; Susan M Richards; rajesh Chopra; Hillard M Lazarus; Mark R Litzow; Georgina Buck; I Jill Durrant; Selina M Luger; David I Marks; Ian M Franklin; Andrew K McMillan; Martin S Tallman; Jacob M Rowe; Anthony H Goldstone
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.
Blood 2007;109(3):944-50.
2007: Eldad J Dann; Rachel Bar-Shalom; Ada Tamir; Nissim Haim; Menachem Ben-Shachar; Irit Avivi; Tsila Zuckerman; Mark Kirschbaum; Odelia Goor; Diana Libster; Jacob M Rowe; Ron Epelbaum
Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome.
Blood 2007;109(3):905-9.
2007: Jacob M Rowe
Innovative approaches in the treatment and support of patients with acute myelogenous leukemia.
The oncologist 2007;12 Suppl 2():1.
2006: Ronit Lavi; David Yarnitsky; D Yernitzky; Jacob M Rowe; A Weissman; D Segal; Irit Avivi
Standard vs atraumatic Whitacre needle for diagnostic lumbar puncture: a randomized trial.
Neurology 2006;67(8):1492-4.
2006: H M Lazarus; Jacob M Rowe
Reduced-intensity conditioning for acute myeloid leukemia: is this strategy correct.
Leukemia 2006;20(10):1673-82.
2006: Hillard M Lazarus; Susan M Richards; rajesh Chopra; Mark R Litzow; Alan K Burnett; Peter H Wiernik; Ian M Franklin; Martin S Tallman; Lucy Cook; Georgina Buck; I Jill Durrant; Jacob M Rowe; Anthony H Goldstone
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993.
Blood 2006;108(2):465-72.
2006: Ilana Oren; Jacob M Rowe; Hannah Sprecher; A Tamir; N Benyamini; Luiza Akria; A Gorelik; N Dally; Tsila Zuckerman; Nuhad Haddad; R Fineman; Eldad J Dann
A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
Bone marrow transplantation 2006;38(2):127-34.
2006: Larry D Cripe; Kevin Rader; Martin S Tallman; Michael S Gordon; Elisabeth Paietta; John Bennett; Donna Neuberg; Mark R Litzow; Timothy E O'brien; Jacob M Rowe
Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997.
Leukemia research 2006;30(7):823-7.
2006: Jacob M Rowe
Is there a role for consolidation therapy pre-transplantation?
Best practice & research. Clinical haematology 2006;19(2):301-10.
2006: Jacob M Rowe
Preface: significant advances in the biology and therapy of AML over the past four decades.
Best practice & research. Clinical haematology 2006;19(2):259-62.
2005: Jacob M Rowe; Georgina Buck; Alan K Burnett; rajesh Chopra; Peter H Wiernik; Susan M Richards; Hillard M Lazarus; Ian M Franklin; Mark R Litzow; Niculae Ciobanu; H Grant Prentice; Jill Durrant; Martin S Tallman; Anthony H Goldstone
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.
Blood 2005;106(12):3760-7.
2005: Yona Nadir; Tamar Katz; Galit Sarig; Ron Hoffman; Anna Oliven; Jacob M Rowe; Benjamin Brenner
Hemostatic balance on the surface of leukemic cells: the role of tissue factor and urokinase plasminogen activator receptor.
Haematologica 2005;90(11):1549-56.
2005: Martin S Tallman; D Gary Gilliland; Jacob M Rowe
Drug therapy for acute myeloid leukemia.
Blood 2005;106(4):1154-63.
2005: Jacob M Rowe
Is there a role for postremission therapy in older adults with acute myelogenous leukemia (AML)?
Leukemia 2005;19(8):1324-7.
2005: Eldad J Dann; Ron Epelbaum; Irit Avivi; Menachem Ben Shahar; Nissim Haim; Jacob M Rowe; Zeev Blumenfeld
Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma.
Human reproduction (Oxford, England) 2005;20(8):2247-9.
2005: Najib Dally; Ron Hoffman; Nuhad Haddad; Galit Sarig; Jacob M Rowe; Benjamin Brenner
Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients.
Thrombosis research 2005;116(2):109-14.
2005: Peter A Cassileth; Sandra J Lee; Mark R Litzow; Kenneth B Miller; Edward A Stadtmauer; Martin S Tallman; Hillard M Lazarus; John M Bennett; Elisabeth Paietta; Gordon W Dewald; Jacob M Rowe
Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995).
Leukemia & lymphoma 2005;46(1):55-61.
2005: Irit Avivi; Jacob M Rowe
Prognostic factors in acute myeloid leukemia.
Current opinion in hematology 2005;12(1):62-7.
2004: Jacob M Rowe
State of the science for myelodysplastic syndrome: prognosis and promise of new therapies.
Best practice & research. Clinical haematology 2004;17(4):535-41.
2004: Nuhad Haddad; Jacob M Rowe
Current indications for reduced-intensity allogeneic stem cell transplantation.
Best practice & research. Clinical haematology 2004;17(3):377-86.
2004: Elisabeth Paietta; Adolfo Ferrando; Donna Neuberg; John M Bennett; Janis Racevskis; Hillard Lazarus; Gordon Dewald; Jacob M Rowe; Peter H Wiernik; Martin S Tallman; A Thomas Look
Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemias.
Blood 2004;104(2):558-60.
2004: Erica Hoffer; Luiza Akria; Arek Tabak; Inna Scherb; Jacob M Rowe; Norberto Krivoy
A simple approximation for busulfan dose adjustment in adult patients undergoing bone marrow transplantation.
Therapeutic drug monitoring 2004;26(3):331-5.
2004: Ronit Elhasid; Jacob M Rowe; Drora Berkowitz; Myriam Weyl Ben Arush; R Bar-Shalom; Riva Brik
Disappearance of diffuse calcinosis following autologous stem cell transplantation in a child with autoimmune disease.
Bone marrow transplantation 2004;33(12):1257-9.
2004: Martin S Tallman; Haesook T Kim; Elisabeth Paietta; John M Bennett; Gordon Dewald; Peter A Cassileth; Peter H Wiernik; Jacob M Rowe
Acute monocytic leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the Eastern Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(7):1276-86.
2004: Peter L Greenberg; Sandra Lee; Ranjana Advani; Martin S Tallman; Branimir I Sikic; Louis Letendre; Kathleen Dugan; Bert L Lum; David L Chin; Gordon Dewald; Elisabeth Paietta; John M Bennett; Jacob M Rowe
Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(6):1078-86.
2004: Adolfo Ferrando; Donna Neuberg; Richard K Dodge; Elisabeth Paietta; Richard A Larson; Peter H Wiernik; Jacob M Rowe; Michael A Caligiuri; Clara D Bloomfield; A Thomas Look
Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
Lancet 2004;363(9408):535-6.
2004: Jacob M Rowe; Donna Neuberg; William Friedenberg; John M Bennett; Elisabeth Paietta; Adel Z Makary; Jane L Liesveld; Camille N Abboud; Gordon Dewald; F Ann Hayes; Martin S Tallman; Peter H Wiernik
A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group.
Blood 2004;103(2):479-85.
2004: Irit Avivi; Ilana Oren; Nuhad Haddad; Jacob M Rowe; Eldad J Dann
Stem cell transplantation post invasive fungal infection is a feasible task.
American journal of hematology 2004;75(1):6-11.
2003: Irit Avivi; Jacob M Rowe
Acute lymphocytic leukemia: role of hematopoietic stem cell transplantation in current management.
Current opinion in hematology 2003;10(6):463-8.
2003: Elisabeth Paietta; Donna Neuberg; John M Bennett; Gordon Dewald; Jacob M Rowe; Peter A Cassileth; Larry D Cripe; Martin S Tallman; Peter H Wiernik
Low expression of the myeloid differentiation antigen CD65s, a feature of poorly differentiated AML in older adults: study of 711 patients enrolled in ECOG trials.
Leukemia 2003;17(8):1544-50.
2003: Dana G Wolf; Nell S Lurain; Tsila Zuckerman; Ron Hoffman; Judith Satinger; Alik Honigman; Niveen Saleh; Emanuel S Robert; Jacob M Rowe; Zipi Kra-Oz
Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients.
Blood 2003;101(2):463-5.
2002: Martin S Tallman; Janet W Andersen; Charles Alan Schiffer; Frederick R Appelbaum; James Feusner; William G Woods; Angela Ogden; Howard Weinstein; Lois Shepherd; Cheryl Willman; Clara D Bloomfield; Jacob M Rowe; Peter H Wiernik
All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.
Blood 2002;100(13):4298-302.
2002: Irit Avivi; Jacob M Rowe; Anthony H Goldstone
Stem cell transplantation in adult ALL patients.
Best practice & research. Clinical haematology 2002;15(4):653-74.
2002: Ilana Oren; Tsila Zuckerman; Irit Avivi; Renato Finkelstein; Mordechai Yigla; Jacob M Rowe
Nosocomial outbreak of Legionella pneumophila serogroup 3 pneumonia in a new bone marrow transplant unit: evaluation, treatment and control.
Bone marrow transplantation 2002;30(3):175-9.
2002: Jacob M Rowe
Therapy of secondary leukemia.
Leukemia 2002;16(4):748-50.
2002: Zeev Blumenfeld; Eldad J Dann; Irit Avivi; Ron Epelbaum; Jacob M Rowe
Fertility after treatment for Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 1():138-47.
2002: Norberto Krivoy; Erica Hoffer; Arek Tabak; Ronit Elhasid; Myriam Weyl Ben Arush; Jerry Stein; Isaac Yaniv; Jacob M Rowe
Therapeutic monitoring of busulfan in pediatric bone marrow transplantation.
Pediatric hematology and oncology 2002;19(1):31-7.
2002: Eldad J Dann; Riva Fineman; Jacob M Rowe
Tumor lysis syndrome after STI571 in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(1):354-5.
2001: Arek Tabak; Erica Hoffer; Jacob M Rowe; Norberto Krivoy
Monitoring of busulfan area under the curve: estimation by a single measurement.
Therapeutic drug monitoring 2001;23(5):526-8.
2001: A Carter; Eldad J Dann; Tamar Katz; Yoram Shechter; Anna Oliven; Ronit Regev; E Eytan; Jacob M Rowe; Gera D Eytan
Cells from chronic myelogenous leukaemia patients at presentation exhibit multidrug resistance not mediated by either MDR1 or MRP1.
British journal of haematology 2001;114(3):581-90.
2001: Jacob M Rowe
Uncertainties in the standard care of acute myelogenous leukemia.
Leukemia 2001;15(4):677-9.
2001: Jacob M Rowe; Hillard M Lazarus
Genetically haploidentical stem cell transplantation for acute leukemia.
Bone marrow transplantation 2001;27(7):669-76.
2001: Ilana Oren; Nuhad Haddad; Renato Finkelstein; Jacob M Rowe
Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters.
American journal of hematology 2001;66(4):257-62.
2001: Eli Zuckerman; T Zuckerman; D Sahar; S Streichman; Dina Attias; Edmond Sabo; D Yeshurun; Jacob M Rowe
The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection.
Blood 2001;97(6):1555-9.
2001: Eldad J Dann; Jacob M Rowe
Biology and therapy of secondary leukaemias.
Best practice & research. Clinical haematology 2001;14(1):119-37.
2001: Elisabeth Paietta; Donna Neuberg; S Richards; John M Bennett; L Han; Janis Racevskis; Gordon Dewald; Jacob M Rowe; Peter H Wiernik
Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity.
American journal of hematology 2001;66(3):189-96.
2001: John M Bennett; M S Young; Jane L Liesveld; Elisabeth Paietta; Kenneth B Miller; Hillard M Lazarus; R D Marsh; W R Friedenberg; H T Saba; F A Hayes; G W Dewald; W Hiddemann; Jacob M Rowe
Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): an Eastern Cooperative Oncology Group Study.
American journal of hematology 2001;66(1):23-7.
2000: Marilyn L Slovak; Kenneth J Kopecky; Peter A Cassileth; D H Harrington; K S Theil; Anwar N Mohamed; Elisabeth Paietta; Cheryl L Willman; David R Head; Jacob M Rowe; Stephen J Forman; Frederick R Appelbaum
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study.
Blood 2000;96(13):4075-83.
2000: Ronit Elhasid; Myriam Weyl Ben Arush; Tamar Katz; Y Gan; Yoram Shechter; I Sami; Sergey Postovsky; Yair Reisner; Jacob M Rowe
Successful haploidentical bone marrow transplantation in Fanconi anemia.
Bone marrow transplantation 2000;26(11):1221-3.
2000: Martin S Tallman; Donna Neuberg; John M Bennett; C J Francois; Elisabeth Paietta; Peter H Wiernik; Gordon Dewald; Peter A Cassileth; Martin M Oken; Jacob M Rowe
Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience.
Blood 2000;96(7):2405-11.
2000: Michael S Gordon; ML Young; Martin S Tallman; Larry D Cripe; J M Bennett; Elisabeth Paietta; W Longo; H Gerad; J Mazza; Jacob M Rowe
Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia: a study of the Eastern Cooperative Oncology Group (ECOG), E5995.
Leukemia research 2000;24(10):871-5.
2000: S Lee; Martin S Tallman; Martin M Oken; Peter A Cassileth; John M Bennett; Peter H Wiernik; Jacob M Rowe
Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia. Eastern Cooperative Oncology Group.
Leukemia 2000;14(8):1345-8.
2000: Ronit Elhasid; Myriam Weyl Ben Arush; S Pollack; K Tavor; S Streichman; Sergey Postovsky; N Haddad; Jacob M Rowe
Immune and hematopoietic reconstitution after transplantation of cord blood progenitor cells: case report and review of the literature.
Leukemia 2000;14(5):931-4.
2000: Jacob M Rowe
Concurrent use of growth factors and chemotherapy in acute leukemia.
Current opinion in hematology 2000;7(3):197-202.
2000: Jacob M Rowe
Treatment of acute myelogenous leukemia in older adults.
Leukemia 2000;14(3):480-7.
2000: Martin S Tallman; Janet W Andersen; Charles Alan Schiffer; Frederick R Appelbaum; James Feusner; Angela Ogden; Lois Shepherd; Jacob M Rowe; C François; Richard Larson; Peter H Wiernik
Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome.
Blood 2000;95(1):90-5.
1999: Zeev Blumenfeld; Irit Avivi; M Ritter; Jacob M Rowe
Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women.
Journal of the Society for Gynecologic Investigation 1999;6(5):229-39.
1999: Martin S Tallman; David Hakimian; Kenneth J Kopecky; S Wheaton; ER Wollins; K Foucar; Peter A Cassileth; Thomas M Habermann; Michael R Grever; Jacob M Rowe; LoAnn C Peterson
Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(7):1665-70.
1999: Ranjana Advani; Hussain I Saba; Martin S Tallman; Jacob M Rowe; P H Wiernik; J Ramek; Kathleen Dugan; Bert L Lum; J Villena; E Davis; Elisabeth Paietta; Litchman Manuel; Branimir I Sikic; Peter L Greenberg
Treatment of refractory and relapsed acute myelogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC 833 (Valspodar).
Blood 1999;93(3):787-95.
1999: Ranjana Advani; G Visani; Donald Milligan; Hussain I Saba; Martin S Tallman; Jacob M Rowe; P H Wiernik; J Ramek; Kathleen Dugan; Bert L Lum; J Villena; E Davis; Elisabeth Paietta; Litchman Manuel; A Covelli; Branimir I Sikic; P Greenberg
Treatment of poor prognosis AML patients using PSC833 (valspodar) plus mitoxantrone, etoposide, and cytarabine (PSC-MEC).
Advances in experimental medicine and biology 1999;457():47-56.
1998: Peter A Cassileth; David Harrington; Frederick R Appelbaum; Hillard M Lazarus; Jacob M Rowe; Elisabeth Paietta; Cheryl L Willman; D D Hurd; John M Bennett; K G Blume; David R Head; Peter H Wiernik
Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission.
The New England journal of medicine 1998;339(23):1649-56.
1998: Elisabeth Paietta; Janis Racevskis; John M Bennett; Donna Neuberg; Peter A Cassileth; Jacob M Rowe; Peter H Wiernik
Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience.
Leukemia 1998;12(12):1881-5.
1998: Jacob M Rowe
What is the best induction regimen for acute myelogenous leukemia?
Leukemia 1998;12 Suppl 1():S16-9.
1998: Elisabeth Paietta; J Andersen; J Yunis; Jacob M Rowe; Peter A Cassileth; Martin S Tallman; John M Bennett; Peter H Wiernik
Acute myeloid leukaemia expressing the leucocyte integrin CD11b-a new leukaemic syndrome with poor prognosis: result of an ECOG database analysis. Eastern Cooperative Oncology Group.
British journal of haematology 1998;100(2):265-72.
1997: Elisabeth Paietta; Janis Racevskis; Donna Neuberg; Jacob M Rowe; A H Goldstone; Peter H Wiernik
Expression of CD25 (interleukin-2 receptor alpha chain) in adult acute lymphoblastic leukemia predicts for the presence of BCR/ABL fusion transcripts: results of a preliminary laboratory analysis of ECOG/MRC Intergroup Study E2993. Eastern Cooperative Oncology Group/Medical Research Council.
Leukemia 1997;11(11):1887-90.
1997: Martin S Tallman; Janet W Andersen; Charles Alan Schiffer; Frederick R Appelbaum; James Feusner; Angela Ogden; Lois Shepherd; C Willman; Clara D Bloomfield; Jacob M Rowe; Peter H Wiernik
All-trans-retinoic acid in acute promyelocytic leukemia.
The New England journal of medicine 1997;337(15):1021-8.
1997: Hillard M Lazarus; Georgia B Vogelsang; Jacob M Rowe
Prevention and treatment of acute graft-versus-host disease: the old and the new. A report from the Eastern Cooperative Oncology Group (ECOG).
Bone marrow transplantation 1997;19(6):577-600.